Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipophilic xenobiotics are chemical substances foreign to an organism, such as drugs, environmental pollutants, and industrial chemicals, that possess high lipid solubility (NIH, 2023). Because they are not easily excreted in their native state, the body utilizes a complex system of biotransformation enzymes, primarily in the liver, to convert these compounds into polar, water-soluble metabolites (StatPearls, 2023). This process typically involves Phase I reactions, such as oxidation by Cytochrome P450 enzymes, followed by Phase II conjugation reactions (PubChem). While these substances are not therapeutic targets themselves, they are the primary substrates for detoxification pathways and can lead to toxicity or carcinogenesis if they accumulate or are converted into reactive intermediates (Wikipedia). Understanding the handling of lipophilic xenobiotics is essential for drug development, as it determines the pharmacokinetic profile and potential for drug-drug interactions of most therapeutic agents (PubMed).
Biotransformation via Phase I (oxidation, reduction, hydrolysis) and Phase II (conjugation) enzymatic pathways to increase water solubility for renal or biliary excretion (StatPearls, 2023).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipophilic xenobiotics.